Neil Smyth Selected Research

nidogen (entactin)

1/2014	Anti-angiogenic effect of the basement membrane protein nidogen-1 in a mouse model of choroidal neovascularization.
1/2010	Impaired wound healing in mice lacking the basement membrane protein nidogen 1.
3/2007	Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture.
12/2006	Loss of nidogen-1 and -2 results in syndactyly and changes in limb development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Smyth Research Topics

Disease

3	Neoplasms (Cancer) 10/2010 - 02/2005
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 02/2007
2	Dermatitis Herpetiformis (Disease, Duhring's) 01/2018 - 03/2002
2	Skin Diseases (Skin Disease) 01/2018 - 03/2002
2	Choroidal Neovascularization 01/2014 - 08/2006
2	Wounds and Injuries (Trauma) 01/2010 - 04/2007
2	Proteinuria 07/2004 - 02/2003
2	Fibrosis (Cirrhosis) 07/2004 - 02/2003
1	Inflammation (Inflammations) 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Wallerian Degeneration 08/2011
1	Sciatic Neuropathy (Lesion of Sciatic Nerve) 08/2011
1	Alopecia (Baldness) 10/2010
1	Cicatrix (Scar) 10/2010
1	Experimental Sarcoma 09/2010
1	Colitis 05/2009
1	Perinatal Death 03/2007
1	Syndactyly (Polysyndactyly) 12/2006
1	Rupture 08/2006
1	Hypoglycemia (Reactive Hypoglycemia) 03/2005
1	Skin Neoplasms (Skin Cancer) 02/2005
1	Amyloid angiopathy 11/2004
1	Chronic Renal Insufficiency 07/2004
1	Uremia 07/2004
1	Cardiac Arrhythmias (Arrythmia) 01/2004
1	Fibrosarcoma 11/2003
1	Hereditary Nephritis (Alport Syndrome) 02/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2003
1	Renal Insufficiency (Renal Failure) 02/2003
1	Asymptomatic Diseases 02/2003
1	Hyperglycemia 04/2002
1	Celiac Disease (Celiac Sprue) 03/2002

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 01/2018 - 03/2002
4	nidogen (entactin)IBA 01/2014 - 12/2006
3	Glutens (Glutelin)IBA 01/2018 - 03/2002
3	Urea (Carbamide)FDA LinkGeneric 07/2004 - 02/2003
2	TransglutaminasesIBA 01/2018 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 11/2004
2	Protein Isoforms (Isoforms)IBA 01/2012 - 08/2011
2	Laminin (Merosin)IBA 09/2010 - 06/2008
2	Pancreatic Elastase (Elastase)IBA 09/2010 - 06/2008
2	Protein Glutamine gamma Glutamyltransferase 2IBA 02/2007 - 03/2002
2	Ramipril (Altace)FDA LinkGeneric 07/2004 - 02/2003
2	Collagen Type IV (Type IV Collagen)IBA 07/2004 - 02/2003
1	EpitopesIBA 01/2018
1	Immunoglobulin E (IgE)IBA 01/2014
1	transglutaminase 1IBA 01/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2010
1	Cystatin MIBA 10/2010
1	Dextrans (Dextran)FDA Link 05/2009
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2009
1	DisulfidesIBA 06/2008
1	Fibronectins (Fibronectin)IBA 04/2007
1	CollagenIBA 04/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2006
1	Retinal Pigments (Pigments, Visual)IBA 08/2006
1	Glucagon (Glukagon)FDA Link 03/2005
1	Blood Glucose (Blood Sugar)IBA 03/2005
1	Viral RNAIBA 02/2005
1	CarcinogensIBA 02/2005
1	Amyloid (Amyloid Fibrils)IBA 11/2004
1	ReninIBA 07/2004
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2004
1	Cell Surface ReceptorsIBA 07/2004
1	candesartanIBA 07/2004
1	SNX 482IBA 01/2004
1	SolutionsIBA 01/2004
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 11/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2003
1	Insulin (Novolin)FDA Link 04/2002
1	Glucose (Dextrose)FDA LinkGeneric 04/2002
1	AntibodiesIBA 03/2002
1	Immunoglobulin A (IgA)IBA 03/2002
1	AutoantigensIBA 03/2002

Therapy/Procedure

1	Light Coagulation 08/2006
1	Lasers (Laser) 08/2006
1	Therapeutics 02/2003
1	Secondary Prevention 02/2003